序贯器官衰竭评分对心脏骤停后综合征患者28天死亡率的预测价值
该研究回顾性分析了温州人民医院EICU 2016年7月至2021年7月收治的125例心脏骤停后综合征(PCAS)患者,收集年龄、性别、基础疾病、APACHE II、入EICU时SOFA评分及28天死亡率。28天内死亡97例、存活28例;死亡组SOFA评分显著高于存活组[11.0(10.0,12.0)分 vs. 9.5(9.0,10.0)分,P<0.05],差异主要来自神经系统和心血管系统;排除神经系统因素后死亡组SOFA评分仍显著高于存活组[8.0(6.0,8.0)分 vs. 6.5(6.0,7.0)分,P<0.05]。多因素Logistic回归显示SOFA评分为28天死亡的独立危险因素(OR=1.97,95%CI 1.24-3.04),神经系统评分与死亡率相关性最高(OR=3.47,95%CI 1.04-11.52)。SOFA评分预测28天死亡的AUC为0.81(95%CI 0.73-0.89),cut-off值10.5分(10或11分)时敏感度67.0%、特异度82.1%。
要点
- 125例PCAS患者中28天死亡97例、存活28例,死亡组入EICU时SOFA评分显著高于存活组[11.0(10.0,12.0)分 vs. 9.5(9.0,10.0)分,P<0.05]。
- 排除神经系统因素后死亡组SOFA评分仍显著高于存活组[8.0(6.0,8.0)分 vs. 6.5(6.0,7.0)分,P<0.05],提示非神经器官衰竭同样与死亡相关。
- 多因素Logistic回归显示SOFA评分为PCAS患者28天死亡的独立危险因素(OR=1.97,95%CI 1.24-3.04)。
- 亚组分析中神经系统评分与死亡率相关性最高(OR=3.47,95%CI 1.04-11.52)。
- SOFA评分预测28天死亡的AUC为0.81(95%CI 0.73-0.89),cut-off值10.5分(10或11分)时敏感度67.0%、特异度82.1%。
适用人群与场景
- 2016年7月至2021年7月在温州人民医院急诊重症监护病房(EICU)治疗的125例心脏骤停后综合征(PCAS)患者,其中男91例、女34例,平均年龄(58.7±15.1)岁。
诊断标准与关键阈值
- SOFA评分预测28天死亡的最佳cut-off值为10.5分(10或11分),此时敏感度67.0%、特异度82.1%。
研究设计与关键结果
- 回顾性分析125例PCAS患者,28天内死亡97例、存活28例;总体SOFA评分范围7~15分,平均10.9(10.0,12.0)分。
- 死亡组SOFA评分显著高于存活组[11.0(10.0,12.0)分 vs. 9.5(9.0,10.0)分,P<0.05],差异主要来自神经系统和心血管系统。
- 排除神经系统因素后,死亡组SOFA评分仍显著高于存活组[8.0(6.0,8.0)分 vs. 6.5(6.0,7.0)分,P<0.05]。
- 多因素Logistic回归显示SOFA评分为28天死亡的独立危险因素(OR=1.97,95%CI 1.24-3.04);亚组中神经系统评分与死亡率相关性最高(OR=3.47,95%CI 1.04-11.52)。
- SOFA评分预测28天死亡的AUC为0.81(95%CI 0.73-0.89)。
证据类型、等级与局限
- 证据类型:回顾性分析;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为SOFA评分对PCAS患者28天死亡率有较好的预测准确性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the predictive value of sequential organ failure assessment (SOFA) for 28-day mortality in patients with post-cardiac arrest syndrome (PCAS).
METHODS: Retrospective analysis of 125 patients with PCAS who were treated in Emergency Intensive Care Unit (EICU) of Wenzhou People's Hospital from July 2016 to July 2021. Clinical data were collected, including age, gender, underlying diseases, acute physiology and chronic health evaluation II (APACHE II), SOFA score on admission to EICU and 28-day mortality. Univariate and multivariate Logistic regression model was constructed to analyze the influencing factors of PCAS patients, which was used to examine the independent correlation between SOFA score and 28-day mortality. Receiver operator characteristic curve (ROC curve) was used to determine the best predictive value of SOFA score and 28-day mortality in PCAS patients.
RESULTS: Among the 125 PCAS patients, there were 91 males and 34 females with an average age of (58.7±15.1) years old, and 97 died and 28 survived within 28 days. The overall SOFA score ranged from 7 to 15 points, with an average of 10.9 (10.0, 12.0) points. The SOFA score of non-survival group was significantly higher than that of the survival group [points: 11.0 (10.0, 12.0) vs. 9.5 (9.0, 10.0), P < 0.05]. This difference between SOFA score mainly caused by the neurological and cardiovascular systems. After excluding neurological factors, the SOFA score of the non-survival group was still significantly higher than that of the survival group [points: 8.0 (6.0, 8.0) vs. 6.5 (6.0, 7.0), P < 0.05]. SOFA score was found to be an independent risk factor for 28-day mortality in PCAS patients by multifactorial Logistic regression analysis [odds ratio (OR) = 1.97, 95% confidence interval (95%CI) was 1.24-3.04]. The correlation between neurological score and mortality was the highest in subgroups (OR = 3.47, 95%CI was 1.04-11.52). The area under the ROC curve (AUC) predicted by SOFA score was 0.81 (95%CI was 0.73-0.89). When SOFA score cut-off value was 10.5 points (10 or 11 points), the sensitivity and specificity of SOFA score for predicting 28-day mortality in patients with PCAS were 67.0% and 82.1%, respectively.
CONCLUSIONS: The SOFA score is quite accurate in predicting 28-day mortality in patients with PCAS.
参考来源
- Lin L, Pan K, Wei X, et al. [Predictive value of sequential organ failure assessment on 28-day mortality in patients with post-cardiac arrest syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36567578. doi:10.3760/cma.j.cn121430-20220117-00068
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。